Journal profile · PERIPHERAL VASCULAR DISEASE
Angiogenesis
ISSN 0969-6970 · eISSN 1573-7209 · Springer Netherlands · NETHERLANDS · Quarterly · Founded 1997
Angiogenesis: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 11.12; hybrid open access; APC about USD 5,490; median 90 days to acceptance (18 articles, last 24 months); 65 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Angiogenesis is published by Springer Netherlands and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Angiogenesis and VEGF in Cancer, Cancer, Hypoxia, and Metabolism and Cell Adhesion Molecules Research, together about 54.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Angiogenesis is an international peer-reviewed journal devoted to the publication of top quality original articles and reviews on the cellular and molecular mechanisms that regulate angiogenesis in physiological and pathological conditions. As a central source for rapid communications representing the full spectrum of angiogenesis research, this multidisciplinary journal will publish innovative experimental studies using molecular, in vitro, animal model systems and clinical investigations of angiogenic diseases. Angiogenesis will also report on novel therapeutic approaches to promote or inhibit angiogenesis as well as new markers and techniques for disease diagnosis and prognosis.
From the journal's Aims & Scope
Research area (LetPub): PERIPHERAL VASCULAR DISEASE
Editor-in-chief Andrew C. DudleyPublisher website
Editorial board by country: none in mainland China; most named United States 17, Netherlands 5, Switzerland 4, Italy 2, United Kingdom 1 (37 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Angiogenesis and VEGF in CancerBiochemistry, Genetics and Molecular Biology36.2%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology10.4%
- Cell Adhesion Molecules ResearchMedicine8%
- Lymphatic System and DiseasesMedicine4.5%
- Protease and Inhibitor MechanismsBiochemistry, Genetics and Molecular Biology3.3%
- Axon Guidance and Neuronal SignalingNeuroscience3.1%
- Retinal Diseases and TreatmentsMedicine3.1%
- Zebrafish Biomedical Research ApplicationsBiochemistry, Genetics and Molecular Biology2.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Peripheral Vascular Disease | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Peripheral Vascular Disease | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Peripheral Vascular Disease | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 11.12LetPub ·
- Impact factor (publisher) 2025
- 11.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 9.2Publisher website ·
- CiteScore 2026-06
- 14.3LetPub ·
- SJR 2026-06
- 2.71LetPub ·
- SNIP 2026-06
- 1.96LetPub ·
- h-index
- 80LetPub ·
- h-index
- 125OpenAlex ·
- i10-index
- 1,026OpenAlex ·
- 2-year mean citedness
- 7.64OpenAlex ·
- Self-citation rate
- 2.7%LetPub ·
- Share of gold OA articles
- 65.63%LetPub ·
Volume
- Articles per year
- 51LetPub ·
- Downloads per year (publisher) 2025
- 596,200Publisher website ·
Articles by year OpenAlex count · 1,515 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 62 | 35 | 22 |
| 2025 | 65 | 41 | 284 |
| 2024 | 60 | 45 | 1,122 |
| 2023 | 36 | 32 | 1,227 |
| 2022 | 41 | 29 | 1,266 |
| 2021 | 65 | 53 | 2,709 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
90 daysMedian, submission to acceptance · P25–P75 60 days – 163 days
- Acceptance to online
- median 33 days (18 articles)
- Submission to online
- median 120 days
- Sample
- 18 articles with submission and acceptance dates (16 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,490 / EUR 4,390 / GBP 3,690 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted11, with length limits
- book reviewNote: Pre-submission inquiries (i.e., article synopsis) are not required and can be difficult to assess reliably. Editors cannot commit to having a contribution…Length not stated
- book reviewsOriginal Articles, Reviews, Short Communications, Letters to the Editor and Book Reviews will be considered for publication.Length not stated
- letterNote: Pre-submission inquiries (i.e., article synopsis) are not required and can be difficult to assess reliably. Editors cannot commit to having a contribution…Length not stated
- letters to the editorNote: Pre-submission inquiries (i.e., article synopsis) are not required and can be difficult to assess reliably. Editors cannot commit to having a contribution…main text ≤ 1,000 words
- original articleNote: Pre-submission inquiries (i.e., article synopsis) are not required and can be difficult to assess reliably. Editors cannot commit to having a contribution…Length not stated
- original articlesOriginal Articles, Reviews, Short Communications, Letters to the Editor and Book Reviews will be considered for publication.Length not stated
- regular articleNote: Pre-submission inquiries (i.e., article synopsis) are not required and can be difficult to assess reliably. Editors cannot commit to having a contribution…Length not stated
- reviewNote: Pre-submission inquiries (i.e., article synopsis) are not required and can be difficult to assess reliably. Editors cannot commit to having a contribution…Length not stated
- reviewsOriginal Articles, Reviews, Short Communications, Letters to the Editor and Book Reviews will be considered for publication.Length not stated
- short communicationNote: Pre-submission inquiries (i.e., article synopsis) are not required and can be difficult to assess reliably. Editors cannot commit to having a contribution…main text ≤ 4,000 words
- short communicationsOriginal Articles, Reviews, Short Communications, Letters to the Editor and Book Reviews will be considered for publication.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
Authors must disclose competing interests. Model summary
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
Data transparency requested. Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
Member of COPE; follows COPE guidelines on misconduct. Model summary
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Angiogenesis, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Reviewer suggestions/exclusions allowed. Model summary
Authors are welcome to suggest suitable reviewers and/or request the exclusion of certain individuals when they submit their manuscripts.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Netherlands
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Quarterly
- Founded
- 1997
- ISSN
- 0969-6970
- Electronic ISSN
- 1573-7209
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Angiogenesis
What CAS zone is Angiogenesis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Angiogenesis is in Zone 1 of Medicine, and in Zone 1 of the minor category Peripheral Vascular Disease; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Angiogenesis?
The latest impact factor listed by LetPub is 11.12; CiteScore 14.3, h-index 125.
How long does peer review take at Angiogenesis?
Based on the dates recorded on 18 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 90 days (interquartile range 60–163 days); authors report an average review time of 6–12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Angiogenesis?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Angiogenesis based?
Of the 37 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (17), Netherlands (5) and Switzerland (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Angiogenesis?
According to LetPub and DOAJ records, Angiogenesis is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Angiogenesis open access, and what is the APC?
Angiogenesis is a hybrid journal. For open-access publication: APC about USD 5,490.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .